You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer

Citation Tools

Article menu
XML
Immunotherapy biomarkers
Original research
Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sato M, Umeda Y, Tsujikawa T, et al
Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
Journal for ImmunoTherapy of Cancer 2021;9:e003079. doi: 10.1136/jitc-2021-003079